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Objective: Because of the prolonged healing time of diabetic foot ulcers, methods for identifying ways to expedite the ulcer
healing process are needed. The angiosome concept delineates the body into three-dimensional blocks of tissue fed by
speciﬁc source arteries. The aim of this study was to evaluate the beneﬁt of infrapopliteal endovascular revascularization
guided by an angiosome model of perfusion in the healing process of diabetic foot ulcers.
Methods: A total of 250 consecutive legs with diabetic foot ulcers in 226 patients who had undergone infrapopliteal
endovascular revascularization in a single center were evaluated. Patient records and periprocedural leg angiograms were
reviewed. The legs were divided into two groups depending on whether direct arterial ﬂow to the site of the foot ulcer
based on the angiosome concept was achieved (direct group) or not achieved (indirect group). Ulcer healing time was
compared between the two groups. A propensity score was used for adjustment of differences in pretreatment covariables
in multivariate analysis and for 1:1 matching.
Results: Direct ﬂow to the angiosome feeding the ulcer area was achieved in 121 legs (48%) compared with indirect re-
vascularization in 129 legs. Foot ulcers treatedwith angiosome-targeted infrapopliteal percutaneous transluminal angioplasty
healed better. The ulcer healing rate was mean (standard deviation) 72% (5%) at 12 months for the direct group compared
with 45% (6%) for the indirect group (P < .001). When adjusted for propensity score, the direct group still had a signiﬁcantly
better ulcer healing rate than the indirect group (hazard ratio, 1.97; 95% conﬁdence interval, 1.34-2.90; P[ .001).
Conclusions: Attaining a direct arterial ﬂow based on the angiosome model of perfusion to the foot ulcer appears to be
important for ulcer healing in diabetic patients. (J Vasc Surg 2013;57:427-35.)Foot ulcers are a common and feared complication of
diabetes. Ischemia, neuropathy, and infection are etiologies
that lead to diabetic foot complications and frequently
occur together. The basic factor preventing healing of a dia-
betic foot ulcer is often inadequate perfusion.1
In diabetics, arterial occlusive disease primarily affects
the crural arteries.2-4 Percutaneous transluminal angio-
plasty (PTA) is increasingly being used as the ﬁrst-line
revascularization procedure for treatment of peripheral
arterial occlusive disease.5,6 Even in the most challenging
areas, such as the infrapopliteal segment, PTA has shown
encouraging leg salvage rates.7
Foot ulcer healing is of major interest because complica-
tions of foot ulcers are the leading cause of hospitalization
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://dx.doi.org/10.1016/j.jvs.2012.07.057that a foot ulcer progresses to major amputation in 8% to
29% of patients with diabetes.9-12 Furthermore, leg ulcers
have important effects on quality of life.13 Ulcer healing
time is seldom reported in lower leg revascularization
studies.14 Despite successful revascularization, ulcer healing
is a very slow process, especially in diabetics.15-17 There is
a need to identify methods that will enhance the healing
process of diabetic foot ulcers. The anatomic location, charac-
teristics of the ulcer, systemic factors, and inadequate local
ulcer treatment can partly explain delayed healing despite
a patent revascularization.18-21 Foot ulcers may fail to heal
because of inadequate arterial perfusion to the speciﬁc ulcer
area.22,23 The aim of this study was to evaluate if infrapopliteal
endovascular revascularization guidedby an angiosomemodel
of perfusionhas abeneﬁcial effect on thehealingprocessofdia-
betic foot ulcers compared with indirect revascularization.24
ANGIOSOME CONCEPT
The angiosome principle, deﬁned by Ian Taylor in his
landmark anatomic study in 1987, divides the body into
three-dimensional anatomic units of tissue supplied by
speciﬁc source arteries.24 Brieﬂy, the foot can be divided
into ﬁve distinct angiosomes originating from the three
main crural arteries: anterior tibial artery (ATA) and pero-
neal artery (PA) supply both one angiosome, whereas
posterior tibial artery (ATP) supplies three angiosomes.
The ATA supplies the dorsal side of the foot and toes,
the PA covers the lateral ankle and lateral heel, and the427
Fig 1. A and B, The medial calcaneal, medial plantar, and lateral plantar and the arteries angiosomes are derived from
the posterior tibial artery (ATP) and cover the lateral heel and the plantar surface of the foot. The dorsalis pedis artery
angiosome, which prolongs the anterior tibial artery (ATA), nourishes the dorsum of the foot, the toes, and the upper
anterior perimalleolar area. The lateral calcaneal artery from the peroneal artery supplies the lateral and plantar aspects
of the heel. Modiﬁed with permission from Alexandrescu V, Söderström M, Venermo M. Angiosome theory: fact or
ﬁction? Scand J Surg 2012;101:125-31.
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heel and ankle (Fig 1).22 Neighboring angiosomes are con-
nected to each other by a network of small collateral
arteries, “the choke vessels,” thus ensuring circulation to
an angiosome if its source artery is occluded.24
METHODS
The study protocol was approved by the Institutional
Review Board of the Department of Surgery, Helsinki
University Central Hospital, Finland.Patients. This retrospective study included all diabetic
patients with foot ulcers (226 patients, 250 legs) who
underwent a technically successful primary PTA procedure
to at least one of the infrapopliteal arteries (ATA, ATP, PA)
in our institution during a 3-year period between January
2007 and January 2011. Patients who had undergone
a previous infrainguinal revascularization were excluded.
Data collection. The patients were retrospectively
collected fromour prospectivelymaintained vascular database
(HUSVasc). The HUSVasc database includes demographic
JOURNAL OF VASCULAR SURGERY
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revascularization details, pre- and postprocedural hemody-
namic measurements, speciﬁc details of vascular reinterven-
tions, type of local ulcer surgery, information on patency,
date of ulcer healing, major amputation, and death. Registry
data of all patients were manually cross-checked with
patients’ records, andanymissingdatawere retrieved fromthe
patients’ records. Data onmajor amputations and death were
cross-checked with data retrieved from the National Institute
of Health and Welfare and the Population Register Centre,
respectively.
Deﬁnitions and classiﬁcations. Patients were consid-
ered to have diabetes if they were on a hyperglycemia
reducing diet, were undergoing insulin treatment, or
were taking oral hypoglycemic medication.
Technical success was deﬁned as PTA of an infrapopli-
teal (ATA, ATP, or PA) occlusive arterial lesion without
residual stenosis of >50%.
A foot ulcer was deﬁned as a full-thickness skin defect
distal to the malleolar level present for at least 2 weeks.
Ulcer location before PTA was registered. Patients with
supramalleolar ulcers were excluded. The University of
Texas Wound Classiﬁcation System (UTWCS) was used
for classifying the depth of the foot ulcer (grade 1 ¼ super-
ﬁcial ulcer; grade 2 ¼ ulcer penetrating to muscle, tendon,
or joint capsule; grade 3 ¼ ulcer penetrating to joint or
bone) and the presence of infection (stage A ¼ nonische-
mic, noninfected ulcer; stage B ¼ nonischemic, infected
ulcer; stage C ¼ noninfected, ischemic ulcer; stage D ¼
infected ischemic ulcer) in the ulcer before PTA.25
Ulcer healing was deﬁned as complete epithelialization
of the tissue defect by secondary intent or after any addi-
tional local ulcer surgery. The foot ulcer was considered
nonhealed if it did not heal during follow-up or the patient
underwent infrainguinal bypass surgery or a major amputa-
tion due to a nonhealing foot ulcer.
Major amputation was deﬁned as an amputation prox-
imal to the ankle level.
Periprocedural angiograms were retrospectively reviewed.
The angiographic status of the ATA, ATP, and PA
was scored as follows: 0 ¼ normal or <20% stenosis; 1 ¼
20%-49% stenosis; 2 ¼ 50%-99% stenosis; 3 ¼ less than
half of the artery occluded; and 4 ¼ half or more of
the artery occluded.26 The dorsal pedal artery was
considered part of the ATA and the plantar artery was
considered part of the ATP.
The patients were divided into two groups depending
on whether direct in-line ﬂow from the aorta to the foot
ulcer based on the angiosome concept was successfully
achieved (direct group) or the ulcerated angiosome was
fed by collaterals from other angiosomes (indirect group).
If the foot ulcer extended over more than one angiosome
territory, the leg was considered to belong to the direct
group if direct ﬂow to the ulcer from at least one crural
artery was achieved with PTA.27
PTA. Our policy is to perform intraluminal PTA as
a ﬁrst-line revascularization procedure for occlusions and
stenosis >50% whenever possible, except for extensivearterial occlusive disease (eg, TASC [TransAtlantic Inter-
Society Consensus] D lesions), as recommended in the
newest TASC document.9 At our institution, if the patient
was unﬁt for infrainguinal bypass surgery or autologous
vein grafts were not available, PTA is considered ﬁrst-line
treatment of extensive arterial occlusive disease. Before
PTA, all patients were taking aspirin (100 mg/d) if not
contraindicated. The PTA techniques conformed to stan-
dard principles. All patients continued lifelong aspirin
therapy, which was accompanied by clopidogrel (75 mg/d)
for 3 months after PTA if not contraindicated.
Wound care. Local wound care was chosen depending
on the characteristics of each lesion. Debridement was per-
formed to remove devitalized tissue. Infected ulcers under-
went surgical revision and microbial therapy according to
bacterial culture results. If primary or secondary closure
was not possible, skin grafting or ﬂaps were considered.
Complementary methods for addressing local tissue gener-
ation were negative-pressure wound therapy and off-
loading whenever indicated.
Follow-up. The ﬁrst follow-up visit at our outpatient
clinic was 1 month after PTA and at 1- to 3-month intervals
thereafter depending on the clinical status of the foot. The
surveillance continued until the ulcer healed. In addition to
the clinical status, follow-up visits included ankle-brachial
index and toe pressure measurements. Duplex scanning
and/or angiography was performed in patients with clinical
deterioration corroborated by ankle-brachial index and toe
pressure ﬁndings. Re-PTA was considered for restenosis
>50%.For this study, follow-upended1year after theprimary
infrapopliteal PTA, or death, whichever occurred ﬁrst.
Outcome measures. The main aim of this study was to
investigate if achievement of direct ﬂow to the foot ulcer
had an effect on ulcer healing time compared with indirect
revascularization according to the angiosome principle.
The secondary aim was to assess the rate of patients alive
with healed ulcers and salvaged leg in both groups.
Statistical analysis. Statistical software package SPSS
version 19.0 (SPSS Inc, Chicago, Ill) was used for statistical
analysis. Comparisons of univariate categorical variables in
each group were computed using c2 test and Fisher exact
test when appropriate. Comparisons of univariate continuous
variables between the two groups were computed via the
Student t-test (normal distribution) or Mann-Whitney
U test (skewed distribution). Kaplan-Meier univariable anal-
ysis was used to estimate cumulative ulcer healing, leg salvage,
survival, and amputation-free survival. Survival rates are re-
ported as proportion (standard error). Life tables between
groups were compared with log-rank test. Cox regression
analysis provided risk ratios of clinically relevant factors for
ulcerhealing.Baseline risk factorshavingP< .20 inunivariable
analysis were included in the regression analysis. Results
are presented as hazard ratio and 95% conﬁdence interval.
The treatment groups were likely to differ with respect
to pretreatment covariables. To account for certain differ-
ences between the direct and indirect groups, a propensity
score was developed for the treatment method. Propensity
score analysis is a post hoc statistical method that estimates
Table I. Characteristics of diabetic patients achieving direct ﬂow to the foot ulcer compared with those having indirect
revascularization according to the angiosome principle
Comorbidity
Overall
(250 legs)
Overall series
P value
Propensity score matched pairs
P value
Direct group
(121 legs)
Indirect group
(129 legs)
Indirect group
(84 legs)
Direct group
(84 legs)
Age, mean (SD) 71.2 (11.8) 68.4 (11.9) 73.8 (11.1) .001 70.3 (10.9) 71.7 (11.0) .416
Female gender 90 (36) 32 (26) 58 (45) .002 26 (31) 25 (30) .867
Diabetes mellitus 250 (100) 121 (100) 129 (100) 1.000 84 (100) 84 (100) 1.000
Dyslipidemia 162 (65) 78 (65) 84 (65) .914 60 (71) 50 (60) .105
Cerebrovascular disease 53 (21) 29 (24) 24 (19) .300 17 (20) 20 (24) .576
Chronic pulmonary disease 41 (16) 21 (17) 20 (16) .693 11 (13) 15 (18) .394
Coronary artery disease 159 (64) 69 (57) 90 (70) .044 55 (66) 53 (63) .747
Hypertension 191 (76) 89 (74) 102 (79) .305 63 (75) 63 (75) 1.000
Serum creatinine, mean (SD), mmol/L 144 (153) 166 (181) 124 (118) .303 137 (142) 146 (162) .978
Estimated glomerular ﬁltration rate
<30 mL/min/1.73m2 or dialysis
39 (16) 26 (22) 13 (10) .012 12 (14) 14 (17) .670
Smokinga 45 (21) 24 (18) 20 (24) .281 15 (20) 18 (25) .442
Bilateral foot ulcers 48 (19) 25 (21) 23 (18) .570 15 (18) 21 (25) .259
Gangrene 89 (36) 49 (41) 40 (31) .106 30 (36) 31 (37) .873
Heel ulcer 42 (17) 19 (16) 23 (18) .653 16 (19) 10 (12) .201
Ulcer extending to bone (UTWCS
grade 3)
137 (55) 72 (60) 65 (50) .148 48 (57) 47 (56) .876
Infected ulcer (UTWCS stage D) 98 (39) 46 (38) 52 (40) .710 32 (38) 31 (37) .873
Carrier of multidrug-resistant bacteria 24 (10) 10 (8) 14 (11) .330 6 (7) 8 (9) .577
Ankle-brachial index,b mean (SD) 0.68 (0.31) 0.73 (0.33) 0.64 (0.29) .087 0.69 (0.29) 0.70 (0.31) .670
Toe pressure, mean (SD), mm Hg 38 (20) 41 (21) 36 (19) .095 37 (19) 39 (20) .814
Percutaneous transluminal angioplasty
of popliteal or suprapopliteal arteries
74 (30) 34 (28) 40 (31) .587 27 (51) 26 (49) .827
SD, Standard deviation; UTWCS, University of Texas Wound Classiﬁcation.
Results are reported for the overall series and for propensity score matched pairs.
Continuous variables are reported as mean (SD), where indicated. Dichotomous variables are reported as count and percentage (in parentheses).
aData available from 219 of 250 patients.
bLegs with ankle-brachial index <1.4.
Table II. Description of angiosome arteries and
endovascularly treated infrapopliteal arteries in the direct
group and the indirect group
Artery
Direct
group,
No. of
legs (%)
Indirect
group,
No. of
legs (%) P value
Peroneal artery 29 (24) 62 (48) <.001
Anterior tibial artery 73 (61) 69 (54) .221
Posterior tibial artery 57 (47) 24 (18) <.001
Score of the angiosome
artery, median
3 4 <.001
Score of the endovascularly
treated artery, median
3 3 .987
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to a speciﬁc treatment group.28,29 It attempts to control for
all known patient factors that might inﬂuence the decision
of whether to perform direct or indirect revascularization
and thus potentially affect the outcome. The propensity
score was calculated by logistic regression with backward
selection by including clinical variables with P < .20 in uni-
variable analysis. Receiver operating characteristic curve
analysis was used to estimate the area under the curve of
the model, predicting the probability of being included in
the study groups. The calculated propensity score wasused for 1:1 matching and for adjustment of the risk in
the overall series. Stratiﬁcation analysis by propensity score
was not performed because of the limited number of
patients included in this series. The 1:1 propensity score
matching between study groups was done according to
a difference in the logit of propensity score of <0.03
between each patient pair in the study groups. Such
a caliber width was equal to 0.2 of the standard deviation
of the logit of the herein calculated propensity score. P <
.05 was considered statistically signiﬁcant.
RESULTS
Of the 250 consecutive legs undergoing infrapopliteal
PTA, direct ﬂow to the foot ulcer based on the angiosome
principle was achieved in 121 legs (48%) compared with
129 legs (52%) in which direct perfusion was not achieved
(Tables I andII).Thereweremore femalepatients in the indi-
rect group than in the direct group (26% vs 45%; P ¼ .002;
Table I). The patients in the indirect group were older than
those in the direct group (77 vs 71 years; P < .001). There
were more patients with end-stage renal disease in the direct
group than in the indirect group (22% vs 10%; P ¼ .012).
Angiographic scores. The occlusive lesions on the
artery perfusing the foot ulcer according to the angiosome
principle were more severe as measured by the angiographic
Legs with unhealed ulcers: 
Direct group: 
121                64                 37                  26                 18     
Indirect group: 
129                79                 56                  41                  29 
Fig 2. Ulcer healing rates in patients with direct and those with indirect perfusion to the foot ulcer after endovascular
revascularization in the overall series (log-rank test, P < .001).
Table III. Results of univariable and multivariable factors associated with ulcer healing in the overall series
Univariate analysis Multivariate analysis
P value HR 95% CI P value
Age .051 0.99 0.98-1.01 .870
Female gender .941 d d d
Coronary artery disease .295 d d d
Chronic pulmonary disease .251 d d d
Cerebrovascular disease .350 d d d
Estimated glomerular ﬁltration rate <30 mL/min/1.73m2 or dialysis .510 d d d
Dyslipidemia .355 d d d
Hypertension .410 d d d
Smoking .528 d d d
Ulcer extending to bone (UTWCS grade 3) .323 d d d
Ulcer with signs of infection (UTWCS stage D) .387 d d d
Presence of multidrug-resistant bacteria .201 d d d
Gangrene .174 0.66 0.44-0.99 .477
Heel ulcer .165 0.64 0.35-1.14 .129
In-line <.001 1.90 1.32-2.73 .001
CI, Conﬁdence interval; HR, hazard ratio; UTWCS, University of Texas Wound Classiﬁcation.
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(P < .001; Table II). The score of the endovascularly treated
infrapopliteal artery was similar in both groups (P ¼ .987).
Ulcer healing. The ulcer healing rates were mean
(standard deviation) 48% (6%) at 6 months and 72% (5%)
at 12 months for the direct group compared with 26%(5%) and 46% (6%) for the indirect group (P < .001; Fig
2). Univariable analysis for predictors of ulcer healing for
the whole study group is reported in Table III. After
multivariable analysis, the achievement of direct in-line
perfusion to the ulcer was the only signiﬁcant indepen-
dent predictor for ulcer healing (Table III).
Legs with unhealed ulcers: 
Direct group:  
84                  47                      24                    16                     12     
Indirect group: 
84                  49                      36                    26                     18
Fig 3. Ulcer healing rates in 84 propensity matched pairs of patients with direct and those with indirect perfusion to
the foot ulcer after percutaneous transluminal angioplasty (log-rank test, P ¼ .021).
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gender, coronary artery disease, gangrene, estimated
glomerular ﬁltration rate <30 mL/min/1.73m2 or dial-
ysis (P ¼ .521 Hosmer-Lemeshow test; area under the
receiver operating characteristic curve, 0.689; 95% conﬁ-
dence interval, 0.62-0.76). When adjusted for propensity
score, the direct group still had a signiﬁcantly better
healing rate than the indirect group (hazard ratio,
1.97; 95% conﬁdence interval, 1.34-2.90; P ¼ .001;
Table I).
Eighty-four propensity-matched pairs with similar
baseline characteristics were obtained. Patients who under-
went direct perfusion to the ulcer had a signiﬁcantly higher
rate of ulcer healing at 12 months (69% [7%] vs 47% [7%];
median time to healing, 5.9 months vs >1 year; log-rank
test, P ¼ .021; Fig 3).
Leg salvage. The 1-year leg salvage rates were 86%
(3%) for the direct group and 77% (4%) for the indirect
group (P ¼ .086).
Survival. The 1-year survival rates were 74% (4%) for
the direct group and 74% (4%) for indirect group (P¼ .646).
Amputation-free survival. The 1-year amputation-
free survival was 65% (4%) for the direct group and 61%
(4%) for the indirect group (P ¼ .360).
Amputation-free survival with healed ulcers. At 1
year after PTA, 41% of patients in the direct group and
26% of patients in the indirect group had achieved ulcer heal-
ing and were alive without a major amputation (P ¼ .012).
Vascular reinterventions. Re-PTA to the initially
revascularized artery was performed to 18 legs (15%) inthe direct group and 21 legs (17%) in the indirect group
(P ¼ .769).
Ten legs (8%) in the direct group and 16 legs (12%) in
the indirect group were treated with a bypass to the infra-
popliteal arteries after PTA (P ¼ .311).
DISCUSSION
To the best of our knowledge, this study represents the
largest study evaluating the inﬂuence of revascularization
based on the angiosome concept in the healing of foot
ulcers.14,23,30,31
The results of this study indicate that providing direct
blood ﬂow to the speciﬁc area of a diabetic foot ulcer has
a favorable effect on ulcer healing and should be preferred
to indirect revascularization. One reason for the superiority
of direct revascularization in this study might be that the
choke vessels in diabetics tend to be compromised.27,32
With indirect revascularization. many diabetic foot ulcers
fail to heal because of inadequate perfusion caused by the
poor vascular connections between angiosomes.
Our results are in agreement with several other studies
evaluating angiosome-guided revascularization in ulcer
healing.6,23,27,30 Alexandrescu et al36 compared the results
of infrapopliteal PTA in diabetics before and after incorpo-
ration of the angiosome-targeted revascularization model
at their institution. Patients undergoing PTA after intro-
duction of the angiosome concept achieved better
ulcer healing and leg salvage compared with those treated
before the introduction of the angiosome concept. It is
worth noting that both patient groups in the study by
JOURNAL OF VASCULAR SURGERY
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rect revascularization. In a personal institutional series of
52 leg revascularizations, Attinger et al22 reported 9% heal-
ing failures when ulcers were treated with angiosome-
targeted bypass surgery compared with 38% lack of success
in healing of ulcers when treated with non-angiosome-
oriented bypass surgery. In another small retrospective
surgical series, Neville et al30 reported an ulcer healing
rate of 91% for patients undergoing bypass to the artery
directly feeding the ulcerated angiosome vs an ulcer healing
rate of 62% for those having indirect revascularization.
Seemingly in line with these reports, Varela et al6 noted
signiﬁcantly better results for ulcer healing (92% vs 73%
at 1 year) in the angiosome-guided cohorts of patients in
their series, including 76 ischemic ulcers treated by bypass
or PTA. The beneﬁcial effect of angiosome-targeted revas-
cularization was not that clear in a retrospective Japanese
analysis that included 249 critically ischemic limbs with
tissue loss treated with distal bypass surgery.31 The ulcer
healing rate was faster if direct revascularization was
possible, but after minimizing the background differences
with the propensity score method the positive effect of
angiosome-targeted bypass surgery disappeared. The prev-
alence of patients with end-stage renal disease was high
(49%) in the Japanese study. Several publications have sug-
gested that the presence of renal failure interferes with ulcer
healing and that patients with renal failure ultimately may
require major amputation.1,33 When performing endovas-
cular revascularization, surgical incisions in the ischemic
leg are avoided and thereby also the possible problems
with incisional wound healing.
Twenty percent of angiosome-oriented endovascular
revascularizations have been reported to be unsuccessful
due to technical barriers and lesion severity.23 Older age is
a well-known risk factor for arterial occlusive disease.9 In
our study, the patients in the indirect group were older,
and the artery perfusing the ulcer exhibited severer occlusive
lesions compared with the direct group. Angiosome-
targeted endovascular procedures can be challenging
because the artery supplying the ulcer might have more
severe atherosclerotic lesions than the other crural arteries.
Leg revascularizations in patients who have diabetes already
are challenging because of the frequently calciﬁed arterial
wall and the distal distribution of arterial occlusive disease.4,5
In the present series, the PA was the target artery in signiﬁ-
cantly more legs of the indirect group compared with the
direct group. The PA has been reported to be relatively
spared from the terminal stage of atherosclerosis and is often
the last tibial vessel to become occluded in diabetics.34
Reliable data on ulcer healing in diabetic population
are scarce.8 Although the Trans Atlantic Conference on
Clinical Trial Guidelines in Peripheral Arterial Occlusive
Disease recommended that ulcer healing be a parameter
when reporting success of revascularization,35 only 1% of
critical leg ischemia studies have reported information on
ulcer healing after leg revascularization.13 One year after
infrainguinal bypass surgery, 63% of diabetic patients
have been reported to achieve complete healing of theincisional wounds and ischemic ulcers.16 Complete ulcer
healing after endovascular revascularization was observed
in 79% of the limbs during 18-month follow-up in the
series by Alexandrescu et al.36 In another series by Alexan-
drescu et al,23 73% of diabetic patients achieved ulcer heal-
ing and returned to ambulation after angiosome-guided
infrapopliteal PTA. In a follow-up of diabetic patients
undergoing PTA, bypass, or conservative treatment for
a mean of 6 years, Faglia et al37 reported that 86% showed
complete healing of the tissue lesions.
In the present study, less than half of the patients in the
direct group and only one fourth of the patients in the indi-
rect group achieved ulcer healing and were alive without
a major amputation 1 year after PTA. These results indicate
that ischemic foot ulcers in diabetics are signs of a severe
disease with considerable risk for ulcer chronicity, major
amputation, and death. Diabetic patients with arterial
insufﬁciency and foot ulcers should be identiﬁed early.38
It has been suggested that the threshold for revasculariza-
tion in diabetic patients with foot ulcer should be lower
than that for nondiabetics.8 This may allow surgeons to
intervene when the disease has not yet become too exten-
sive for beneﬁcial intervention.
This study had some limitations. First, this was a retro-
spective, nonrandomized study of a prospectively main-
tained database. Because there were differences in the
baseline characteristics of the groups, adjustment was per-
formed by propensity score analysis. The morphology of
the infrapopliteal arterial occlusive lesions was not included
in the analysis due to a lack of proper classiﬁcation.39,40
Second, the angiosome areas may show individual varia-
tions. Third, the wound size could not be retrospectively
evaluated and the wound care was not standardized, which
might have inﬂuenced ulcer healing time. However, there
is no evidence that any wound dressing or local ulcer treat-
ment method is better than another for speeding up the
ulcer healing process.19,41 Fourth, glucose levels might
interfere with ulcer healing. Due to the retrospective nature
of the study, we could not obtain information about how
well glucose levels were controlled.
The angiosome concept may be more relevant for
endovascular revascularizations than for bypass surgery.
Endovascular technique more often offers the option to
reopen multiple vessels than bypass surgery. Angiosome-
guided bypass surgery is not always possible due to infec-
tion, extensive tissue loss, and severe arterial occlusive
disease, including absence of runoff.31 Efforts to opening
the feeding artery of the ulcerated angiosome may require
more skills, more time, and more redo procedures. A larger
clinical experience in randomized and prospective studies is
needed to evaluate the potential advantages or drawbacks
of angiosome-oriented revascularization.AUTHOR CONTRIBUTIONS
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